BRIEF-CSPC Pharmaceutical Group Says FY Prelim Net Profit Attributable Expected To Increase By 15% To 30%

Jan 22 (Reuters) - CSPC Pharmaceutical Group Ltd:

* CSPC PHARMACEUTICAL GROUP LTD - FY PRELIM NET PROFIT ATTRIBUTABLE EXPECTED TO INCREASE BY 15% TO 30% VERSUS LAST YEAR Source text for Eikon: Further company coverage: